CoChat

Single-Cell RNA Sequencing in Multiple Pathologic Types of Renal Cell Carcinoma Revealed Novel Potential Tumor-Specific Markers

Open access
Su, Cheng, Lv, Yufang, Lu, Wenhao, Yu, Zhenyuan, Ye, Yu, Guo, Bingqian, Liu, Deyun, Yan, Haibiao, Li, Tianyu, Zhang, Qingyun, Cheng, Jiwen, Mo, Zengnan · 2021 · Frontiers in Oncology
Cited by 115

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Abstract

Background: Renal cell carcinoma (RCC) is the most common type of kidney cancer. Studying the pathogenesis of RCC is particularly important, because it could provide a direct guide for clinical treatment. Given that tumor heterogeneity is probably reflected at the mRNA level, the study of mRNA in RCC may reveal some potential tumor-specific markers, especially single-cell RNA sequencing (scRNA-seq). Methods: We performed an exploratory study on three pathological types of RCC with a small sample size. This study presented clear-cell RCC (ccRCC), type 2 pRCC, and chRCC in a total of 30,263 high-quality single-cell transcriptome information from three pathological types of RCC. In addition, scRNA-seq was performed on normal kidneys. Tumor characteristics were well identified by the comparison between different pathological types of RCC and normal kidneys at the scRNA level. Results: Some new tumor-specific markers for different pathologic types of RCC, such as SPOCK1, PTGIS, REG1A, CP and SPAG4 were identified and validated. We also discovered that NDUFA4L2 both highly expressed in tumor cells of ccRCC and type 2 pRCC. The presence of two different types of endothelial cells in ccRCC and type 2 pRCC was also identified and verified. An endothelial cell in ccRCC may be associated with fibroblasts and significantly expressed fibroblast markers, such as POSTN and COL3A1. At last, by applying scRNA-seq results, the activation of drug target pathways and sensitivity to drug responses was predicted in different pathological types of RCC. Conclusions: Taken together, these findings considerably enriched the single-cell transcriptomic information for RCC, thereby providing new insights into the diagnosis and treatment of RCC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fonc.2021.719564

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 57

  1. Hsieh, 2017, Renal Cell Carcinoma, Nat Rev Dis Primers, 3, 17009, 10.1038/nrdp.2017.9 · DOI · Paper page
  2. Barata, 2017, Treatment of Renal Cell Carcinoma: Current Status and Future Directions, CA Cancer J Clin, 67, 10.3322/caac.21411 · DOI · Paper page
  3. Capitanio, 2019, Epidemiology of Renal Cell Carcinoma, Eur Urol, 75, 74, 10.1016/j.eururo.2018.08.036 · DOI · Paper page
  4. Cho, 2011, Epidemiology of Renal Cell Cancer, Hematol Oncol Clin North Am, 25, 10.1016/j.hoc.2011.04.002 · DOI
  5. Ferlay, 2018, Cancer Incidence and Mortality Patterns in Europe: Estimates for 40 Countries and 25 Major Cancers in 2018, Eur J Cancer (Oxford Engl 1990), 103, 10.1016/j.ejca.2018.07.005 · DOI · Paper page
  6. Cairns, 2010, Renal Cell Carcinoma, Cancer Biomark, 9, 10.3233/cbm-2011-0176 · DOI · Paper page
  7. Athar, 2008, Treatment Options for Metastatic Renal Cell Carcinoma: A Review, Can J Urol, 15
  8. Ljungberg, 2019, European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update, Eur Urol, 75, 799, 10.1016/j.eururo.2019.02.011 · DOI · Paper page
  9. de Velasco, 2019, Sequencing and Combination of Systemic Therapy in Metastatic Renal Cell Carcinoma, Eur Urol Oncol, 2, 10.1016/j.euo.2019.06.022 · DOI
  10. Massari, 2021, Immune-Based Combinations for the Treatment of Metastatic Renal Cell Carcinoma: A Meta-Analysis of Randomised Clinical Trials, Eur J Cancer (Oxford Engl 1990), 154, 10.1016/j.ejca.2021.06.015 · DOI
  11. Hakimi, 2013, A Clear Picture of Renal Cell Carcinoma, Nat Genet, 45, 10.1038/ng.2708 · DOI
  12. Linehan, 2010, The Genetic Basis of Kidney Cancer: A Metabolic Disease, Nat Rev Urol, 7, 10.1038/nrurol.2010.47 · DOI · Paper page
  13. Krishna, 2021, Single-Cell Sequencing Links Multiregional Immune Landscapes and Tissue-Resident T?cells in ccRCC to Tumor Topology and Therapy Efficacy, Cancer Cell, 39, 662, 10.1016/j.ccell.2021.03.007 · DOI · Paper page
  14. Braun, 2021, Progressive Immune Dysfunction With Advancing Disease Stage in Renal Cell Carcinoma, Cancer Cell, 39, 632, 10.1016/j.ccell.2021.02.013 · DOI · Paper page
  15. Bi, 2021, Tumor and Immune Reprogramming During Immunotherapy in Advanced Renal Cell Carcinoma, Cancer Cell, 39, 649, 10.1016/j.ccell.2021.02.015 · DOI · Paper page
  16. Young, 2021, Single Cell Derived mRNA Signals Across Human Kidney Tumors, Nat Commun, 12, 3896, 10.1038/s41467-021-23949-5 · DOI · Paper page
  17. Zhang, 2021, Single-Cell Analyses of Renal Cell Cancers Reveal Insights Into Tumor Microenvironment, Cell of Origin, and Therapy Response, Proc Natl Acad Sci USA, 118, 10.1073/pnas.2103240118 · DOI · Paper page
  18. Liao, 2020, Single-Cell RNA Sequencing of Human Kidney, Sci Data, 7, 4, 10.1038/s41597-019-0351-8 · DOI · Paper page
  19. Stuart, 2019, Comprehensive Integration of Single-Cell Data, Cell, 177, 1888, 10.1016/j.cell.2019.05.031 · DOI · Paper page
  20. Stewart, 2019, Spatiotemporal Immune Zonation of the Human Kidney, Science, 365, 10.1126/science.aat5031 · DOI · Paper page
  21. Park, 2018, Single-Cell Transcriptomics of the Mouse Kidney Reveals Potential Cellular Targets of Kidney Disease, Sci (New York N.Y.), 360, 10.1126/science.aar2131 · DOI · Paper page
  22. MacArthur, 2017, The New NHGRI-EBI Catalog of Published Genome-Wide Association Studies (GWAS Catalog), Nucleic Acids Res, 45, D896, 10.1093/nar/gkw1133 · DOI · Paper page
  23. Ashburner, 2000, Gene Ontology: Tool for the Unification of Biology. The Gene Ontology Consortium, Nat Genet, 25, 10.1038/75556 · DOI · Paper page
  24. Kumar, 2018, Analysis of Single-Cell RNA-Seq Identifies Cell-Cell Communication Associated With Tumor Characteristics, Cell Rep, 25, 1458, 10.1016/j.celrep.2018.10.047 · DOI · Paper page
  25. Ricketts, 2016, SnapShot: Renal Cell Carcinoma, Cancer Cell, 29, 610, 10.1016/j.ccell.2016.03.021 · doi:10.1016/j.ccell.2016.03.021
  26. Turajlic, 2015, SnapShot: Renal Cell Carcinoma, Cell, 163, 1556, 10.1016/j.cell.2015.11.026 · doi:10.1016/j.cell.2015.11.026
  27. Gatza, 2010, A Pathway-Based Classification of Human Breast Cancer, Proc Natl Acad Sci USA, 107, 10.1073/pnas.0912708107 · DOI · Paper page
  28. Skala, 2020, Next-Generation RNA Sequencing-Based Biomarker Characterization of Chromophobe Renal Cell Carcinoma and Related Oncocytic Neoplasms, Eur Urol, 78, 63, 10.1016/j.eururo.2020.03.003 · DOI
  29. Zhang, 2019, Probabilistic Cell-Type Assignment of Single-Cell RNA-Seq for Tumor Microenvironment Profiling, Nat Methods, 16, 10.1038/s41592-019-0529-1 · DOI · Paper page
  30. Newman, 2015, Robust Enumeration of Cell Subsets From Tissue Expression Profiles, Nat Methods, 12, 10.1038/nmeth.3337 · DOI · Paper page
  31. Dutertre, 2019, Single-Cell Analysis of Human Mononuclear Phagocytes Reveals Subset-Defining Markers and Identifies Circulating Inflammatory Dendritic Cells, Immunity, 51, 573, 10.1016/j.immuni.2019.08.008 · DOI · Paper page
  32. Wang, 2017, NDUFA4L2 is Associated With Clear Cell Renal Cell Carcinoma Malignancy and is Regulated by ELK1, PeerJ, 5, 10.7717/peerj.4065 · DOI
  33. Aird, 2007, Phenotypic Heterogeneity of the Endothelium: II. Representative Vascular Beds, Circ Res, 100, 10.1161/01.RES.0000255690.03436.ae · DOI · Paper page
  34. Han, 2004, Secreted Frizzled-Related Protein 1 (SFRP1) Protects Fibroblasts From Ceramide-Induced Apoptosis, J Biol Chem, 279, 10.1074/jbc.M308102200 · DOI
  35. LeBleu, 2013, Origin and Function of Myofibroblasts in Kidney Fibrosis, Nat Med, 19, 10.1038/nm.3218 · DOI · Paper page
  36. Lennon, 2014, Global Analysis Reveals the Complexity of the Human Glomerular Extracellular Matrix, J Am Soc Nephrol, 25, 10.1681/asn.2013030233 · DOI · Paper page
  37. Varga, 1987, Transforming Growth Factor Beta (TGF Beta) Causes a Persistent Increase in Steady-State Amounts of Type I and Type III Collagen and Fibronectin mRNAs in Normal Human Dermal Fibroblasts, Biochem J, 247, 597, 10.1042/bj2470597 · DOI · Paper page
  38. Iwano, 2002, Evidence That Fibroblasts Derive From Epithelium During Tissue Fibrosis, J Clin Invest, 110, 10.1172/jci15518 · doi:10.1172/jci15518 · Paper page
  39. Chen, 2018, PBMC Fixation and Processing for Chromium Single-Cell RNA Sequencing, J Transl Med, 16, 198, 10.1186/s12967-018-1578-4 · DOI · Paper page
  40. Jordan, 2001, Immunohistochemical Properties of Bone Marrow Mast Cells in Systemic Mastocytosis: Evidence for Expression of CD2, CD117/Kit, and Bcl-X(L), Hum Pathol, 32, 10.1053/hupa.2001.24319 · DOI
  41. Sugita, 2018, Natural Killer Cell Inhibition by HLA-E Molecules on Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelial Cells, Invest Ophthalmol Visual Sci, 59, 10.1167/iovs.17-22703 · DOI
  42. Welle, 1997, Development, Significance, and Heterogeneity of Mast Cells With Particular Regard to the Mast Cell-Specific Proteases Chymase and Tryptase, J leukocyte Biol, 61, 10.1002/jlb.61.3.233 · DOI · Paper page
  43. Colpitts, 2009, IL-7 Receptor Expression Provides the Potential for Long-Term Survival of Both CD62Lhigh Central Memory T Cells and Th1 Effector Cells During Leishmania Major Infection, J Immunol (Baltimore Md. 1950), 182, 10.4049/jimmunol.0803450 · DOI · Paper page
  44. Chevrier, 2017, An Immune Atlas of Clear Cell Renal Cell Carcinoma, Cell, 169, 736, 10.1016/j.cell.2017.04.016 · DOI · Paper page
  45. Baldewijns, 2010, VHL and HIF Signalling in Renal Cell Carcinogenesis, J Pathol, 221, 10.1002/path.2689 · DOI · Paper page
  46. LeBleu, 2018, A Peek Into Cancer-Associated Fibroblasts: Origins, Functions and Translational Impact, Dis Model Mech, 11, dmm029447, 10.1242/dmm.029447 · DOI · Paper page
  47. Behnes, 2014, Tumor-Associated Macrophages are Involved in Tumor Progression in Papillary Renal Cell Carcinoma, Virchows Arch, 464, 10.1007/s00428-013-1523-0 · DOI
  48. Yu, 2021, Single-Cell RNA-Seq Identification of the Cellular Molecular Characteristics of Sporadic Bilateral Clear Cell Renal Cell Carcinoma, Front Oncol, 11, 10.3389/fonc.2021.659251 · DOI
  49. Hu, 2017, hTERT Promotes the Invasion of Gastric Cancer Cells by Enhancing FOXO3a Ubiquitination and Subsequent ITGB1 Upregulation, Gut, 66, 31, 10.1136/gutjnl-2015-309322 · DOI
  50. Zhang, 2018, CD31 Regulates Metastasis by Inducing Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma via the ITGB1-FAK-Akt Signaling Pathway, Cancer Lett, 429, 29, 10.1016/j.canlet.2018.05.004 · DOI
  51. Erdem, 2014, Up-Regulation of TGM2 With ITGB1 and SDC4 is Important in the Development and Metastasis of Renal Cell Carcinoma, Urol Oncol, 32, 10.1016/j.urolonc.2012.08.022 · doi:10.1016/j.urolonc.2012.08.022
  52. Geeleher, 2014, Clinical Drug Response can be Predicted Using Baseline Gene Expression Levels and In Vitro Drug Sensitivity in Cell Lines, Genome Biol, 15, R47, 10.1186/gb-2014-15-3-r47 · DOI · Paper page
  53. Gerlinger, 2012, Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing, N Engl J Med, 366, 10.1056/NEJMoa1113205 · DOI · Paper page
  54. Moschetta, 2014, Role of Endothelial Progenitor Cells in Cancer Progression, Biochim Biophys Acta, 1846, 26, 10.1016/j.bbcan.2014.03.005 · DOI
  55. Mura, 2012, Identification and Angiogenic Role of the Novel Tumor Endothelial Marker CLEC14A, Oncogene, 31, 293, 10.1038/onc.2011.233 · DOI
  56. Melincovici, 2018, Vascular Endothelial Growth Factor (VEGF) - Key Factor in Normal and Pathological Angiogenesis, Rom J Morphol Embryol, 59
  57. Herbert, 2011, Molecular Control of Endothelial Cell Behaviour During Blood Vessel Morphogenesis, Nat Rev Mol Cell Biol, 12, 10.1038/nrm3176 · DOI · Paper page

Cited by

See all 115

Metadata

Authors
Su, C., Lv, Y., Lu, W., Yu, Z., Ye, Y., Guo, B., Liu, D., Yan, H., Li, T., Zhang, Q., Cheng, J., & Mo, Z.
Venue
Frontiers in Oncology
Published
2021-10-14
Volume
11
Pages
719564-719564
ISSN
2234-943X (ISSN-L)
OpenAlex
W3205985210
Cited by
115
References
23
FWCI
10.21
Type
journal article
Language
en
Open access
gold
Funders
  • National Natural Science Foundation of China (81770759)
  • Specific Research Project of Guangxi for Research Bases and Talents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.